-
3
-
-
77954337682
-
Soft tissue sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
-
Casali PG, Blay JY Soft tissue sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2010, 21(suppl 5):v198-v203.
-
(2010)
Ann Oncol
, vol.21
, Issue.SUPPL. 5
, pp. 5198-5203
-
-
Casali, P.G.1
Blay, J.Y.2
-
4
-
-
77954333247
-
Bone sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
-
Hogendoorn PC, Athanasou N, Bielack S, et al. Bone sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2010, 21(suppl 5):v204-v213.
-
(2010)
Ann Oncol
, vol.21
, Issue.SUPPL. 5
, pp. 5204-5213
-
-
Hogendoorn, P.C.1
Athanasou, N.2
Bielack, S.3
-
5
-
-
66549093802
-
Osteosarcoma: ESMO clinical recommendations for diagnosis, treatment and follow-up
-
Bielack S, Carrle D, Casali PG Osteosarcoma: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol 2009, 20(suppl 4):137-139.
-
(2009)
Ann Oncol
, vol.20
, Issue.SUPPL. 4
, pp. 137-139
-
-
Bielack, S.1
Carrle, D.2
Casali, P.G.3
-
6
-
-
66649094233
-
Ewing's sarcoma of the bone: ESMO clinical recommendations for diagnosis, treatment and follow-up
-
Paulussen M, Bielack S, Jurgens H, Casali PG Ewing's sarcoma of the bone: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol 2009, 20(suppl 4):140-142.
-
(2009)
Ann Oncol
, vol.20
, Issue.SUPPL. 4
, pp. 140-142
-
-
Paulussen, M.1
Bielack, S.2
Jurgens, H.3
Casali, P.G.4
-
7
-
-
77953502245
-
Guidelines for the management of soft tissue sarcomas
-
Grimer R, Judson I, Peake D, Seddon B Guidelines for the management of soft tissue sarcomas. Sarcoma 2010, 2010:506182.
-
(2010)
Sarcoma
, vol.2010
, pp. 506182
-
-
Grimer, R.1
Judson, I.2
Peake, D.3
Seddon, B.4
-
8
-
-
79952215751
-
UK guidelines for the management of bone sarcomas
-
Grimer R, Athanasou N, Gerrand C, et al. UK guidelines for the management of bone sarcomas. Sarcoma 2010, 2010:317462.
-
(2010)
Sarcoma
, vol.2010
, pp. 317462
-
-
Grimer, R.1
Athanasou, N.2
Gerrand, C.3
-
9
-
-
66149135224
-
International osteosarcoma incidence patterns in children and adolescents, middle ages and elderly persons
-
Mirabello L, Troisi RJ, Savage SA International osteosarcoma incidence patterns in children and adolescents, middle ages and elderly persons. Int J Cancer 2009, 125:229-234.
-
(2009)
Int J Cancer
, vol.125
, pp. 229-234
-
-
Mirabello, L.1
Troisi, R.J.2
Savage, S.A.3
-
10
-
-
0028084916
-
International variations in the incidence of childhood soft-tissue sarcomas
-
Stiller C, Parkint D International variations in the incidence of childhood soft-tissue sarcomas. Paediatr Perinat Epidemiol 1994, 8:107-119.
-
(1994)
Paediatr Perinat Epidemiol
, vol.8
, pp. 107-119
-
-
Stiller, C.1
Parkint, D.2
-
11
-
-
0032248432
-
International incidence of childhood cancer, vol. II
-
Parkin D, Kramarova E, Draper G, et al. International incidence of childhood cancer, vol. II. IARC Sci Publ 1998, 144:1-391.
-
(1998)
IARC Sci Publ
, vol.144
, pp. 1-391
-
-
Parkin, D.1
Kramarova, E.2
Draper, G.3
-
12
-
-
35649014764
-
International patterns of cancer incidence in adolescents
-
Stiller CA International patterns of cancer incidence in adolescents. Cancer Treat Rev 2007, 33:631-645.
-
(2007)
Cancer Treat Rev
, vol.33
, pp. 631-645
-
-
Stiller, C.A.1
-
13
-
-
84886699326
-
-
Central Intelligence Agency, (accessed Sept 10, 2013).
-
The world factbook 2013-14 Central Intelligence Agency, (accessed Sept 10, 2013). https://www.cia.gov/library/publications/the-world-factbook/index.html.
-
The world factbook 2013-14
-
-
-
14
-
-
79251619229
-
Health and health-care systems in southeast Asia: diversity and transitions
-
Chongsuvivatwong V, Phua KH, Yap MT, et al. Health and health-care systems in southeast Asia: diversity and transitions. Lancet 2011, 377:429-437.
-
(2011)
Lancet
, vol.377
, pp. 429-437
-
-
Chongsuvivatwong, V.1
Phua, K.H.2
Yap, M.T.3
-
15
-
-
84886704038
-
-
OECD Secretariat, (accessed Sept 24, 2013).
-
Growth, employment and inequality in Brazil, China, India and South Africa: an overview OECD Secretariat, (accessed Sept 24, 2013). http://www.oecd.org/employment/emp/45282661.pdf.
-
Growth, employment and inequality in Brazil, China, India and South Africa: an overview
-
-
-
16
-
-
56449100677
-
Guideline implementation for breast healthcare in low-income and middle-income countries
-
Anderson BO, Yip CH, Smith RA, et al. Guideline implementation for breast healthcare in low-income and middle-income countries. Cancer 2008, 113:2221-2243.
-
(2008)
Cancer
, vol.113
, pp. 2221-2243
-
-
Anderson, B.O.1
Yip, C.H.2
Smith, R.A.3
-
17
-
-
71249155601
-
Management of endometrial cancer in Asia: consensus statement from the Asian Oncology Summit 2009
-
Tangjitgamol S, Anderson BO, See HT, et al. Management of endometrial cancer in Asia: consensus statement from the Asian Oncology Summit 2009. Lancet Oncol 2009, 10:1119-1127.
-
(2009)
Lancet Oncol
, vol.10
, pp. 1119-1127
-
-
Tangjitgamol, S.1
Anderson, B.O.2
See, H.T.3
-
18
-
-
71249126197
-
Management of hepatocellular carcinoma in Asia: consensus statement from the Asian Oncology Summit 2009
-
Poon D, Anderson BO, Chen LT, et al. Management of hepatocellular carcinoma in Asia: consensus statement from the Asian Oncology Summit 2009. Lancet Oncol 2009, 10:1111-1118.
-
(2009)
Lancet Oncol
, vol.10
, pp. 1111-1118
-
-
Poon, D.1
Anderson, B.O.2
Chen, L.T.3
-
19
-
-
71549117595
-
First-line systemic treatment of advanced stage non-small-cell lung cancer in Asia: consensus statement from the Asian Oncology Summit 2009
-
Soo RA, Anderson BO, Cho BC, et al. First-line systemic treatment of advanced stage non-small-cell lung cancer in Asia: consensus statement from the Asian Oncology Summit 2009. Lancet Oncol 2009, 10:1102-1110.
-
(2009)
Lancet Oncol
, vol.10
, pp. 1102-1110
-
-
Soo, R.A.1
Anderson, B.O.2
Cho, B.C.3
-
20
-
-
71249097862
-
Management of T-cell and natural-killer-cell neoplasms in Asia: consensus statement from the Asian Oncology Summit 2009
-
Kwong YL, Anderson BO, Advani R, Kim WS, Levine AM, Lim ST Management of T-cell and natural-killer-cell neoplasms in Asia: consensus statement from the Asian Oncology Summit 2009. Lancet Oncol 2009, 10:1093-1101.
-
(2009)
Lancet Oncol
, vol.10
, pp. 1093-1101
-
-
Kwong, Y.L.1
Anderson, B.O.2
Advani, R.3
Kim, W.S.4
Levine, A.M.5
Lim, S.T.6
-
21
-
-
71249160153
-
Management of the neck after chemoradiotherapy for head and neck cancers in Asia: consensus statement from the Asian Oncology Summit 2009
-
Wee JT, Anderson BO, Corry J, et al. Management of the neck after chemoradiotherapy for head and neck cancers in Asia: consensus statement from the Asian Oncology Summit 2009. Lancet Oncol 2009, 10:1086-1092.
-
(2009)
Lancet Oncol
, vol.10
, pp. 1086-1092
-
-
Wee, J.T.1
Anderson, B.O.2
Corry, J.3
-
22
-
-
71549153340
-
Management of HER2-positive breast cancer in Asia: consensus statement from the Asian Oncology Summit 2009
-
Wong NS, Anderson BO, Khoo KS, Ang PT, Yip CH, Lu YS, et al. Management of HER2-positive breast cancer in Asia: consensus statement from the Asian Oncology Summit 2009. Lancet Oncol 2009, 10:1077-1085.
-
(2009)
Lancet Oncol
, vol.10
, pp. 1077-1085
-
-
Wong, N.S.1
Anderson, B.O.2
Khoo, K.S.3
Ang, P.T.4
Yip, C.H.5
Lu, Y.S.6
-
23
-
-
84868128705
-
Supportive, palliative, and end-of-life care for patients with cancer in Asia: resource-stratified guidelines from the Asian Oncology Summit 2012
-
Payne S, Chan N, Davies A, Poon E, Connor S, Goh C Supportive, palliative, and end-of-life care for patients with cancer in Asia: resource-stratified guidelines from the Asian Oncology Summit 2012. Lancet Oncol 2012, 13:e492-e500.
-
(2012)
Lancet Oncol
, vol.13
-
-
Payne, S.1
Chan, N.2
Davies, A.3
Poon, E.4
Connor, S.5
Goh, C.6
-
24
-
-
84868089265
-
Management of kidney cancer in Asia: resource-stratified guidelines from the Asian Oncology Summit 2012
-
Chiong E, Tay MH, Tan MH, et al. Management of kidney cancer in Asia: resource-stratified guidelines from the Asian Oncology Summit 2012. Lancet Oncol 2012, 13:e482-e491.
-
(2012)
Lancet Oncol
, vol.13
-
-
Chiong, E.1
Tay, M.H.2
Tan, M.H.3
-
25
-
-
84868126903
-
Management of colon cancer: resource-stratified guidelines from the Asian Oncology Summit 2012
-
Ku G, Tan IB, Yau T, Boku N, Laohavinij S, Cheng AL, et al. Management of colon cancer: resource-stratified guidelines from the Asian Oncology Summit 2012. Lancet Oncol 2012, 13:e470-e481.
-
(2012)
Lancet Oncol
, vol.13
-
-
Ku, G.1
Tan, I.B.2
Yau, T.3
Boku, N.4
Laohavinij, S.5
Cheng, A.L.6
-
26
-
-
0742300931
-
-
National Institute for Health and Clinical Excellence, (accessed Aug 12, 2013).
-
Guidance on cancer services-improving outcomes for people with sarcoma National Institute for Health and Clinical Excellence, (accessed Aug 12, 2013). http://www.nice.org.uk/nicemedia/live/10903/28938/28938.pdf.
-
Guidance on cancer services-improving outcomes for people with sarcoma
-
-
-
27
-
-
70149089478
-
The multidisciplinary management of osteosarcoma
-
Federman N, Bernthal N, Eilber FC, Tap WD The multidisciplinary management of osteosarcoma. Curr Treat Options Oncol 2009, 10:82-93.
-
(2009)
Curr Treat Options Oncol
, vol.10
, pp. 82-93
-
-
Federman, N.1
Bernthal, N.2
Eilber, F.C.3
Tap, W.D.4
-
28
-
-
17644424627
-
National survival trends of young adults with sarcoma
-
Bleyer A, Montello M, Budd T, Saxman S National survival trends of young adults with sarcoma. Cancer 2005, 103:1891-1897.
-
(2005)
Cancer
, vol.103
, pp. 1891-1897
-
-
Bleyer, A.1
Montello, M.2
Budd, T.3
Saxman, S.4
-
29
-
-
78650445486
-
Adolescent and young adult oncology: an emerging field
-
Thomas DM, Albritton KH, Ferrari A Adolescent and young adult oncology: an emerging field. J Clin Oncol 2010, 28:4781-4782.
-
(2010)
J Clin Oncol
, vol.28
, pp. 4781-4782
-
-
Thomas, D.M.1
Albritton, K.H.2
Ferrari, A.3
-
30
-
-
0035690203
-
Computed tomography of pulmonary metastases from osteosarcoma: the less poor technique. A study of 51 patients with histological correlation
-
Picci P, Vanel D, Briccoli A, et al. Computed tomography of pulmonary metastases from osteosarcoma: the less poor technique. A study of 51 patients with histological correlation. Ann Oncol 2001, 12:1601-1604.
-
(2001)
Ann Oncol
, vol.12
, pp. 1601-1604
-
-
Picci, P.1
Vanel, D.2
Briccoli, A.3
-
31
-
-
49549103084
-
Imaging strategy for detecting lung metastases at presentation in patients with soft tissue sarcomas
-
Christie-Large M, James SL, Tiessen L, Davies AM, Grimer RJ Imaging strategy for detecting lung metastases at presentation in patients with soft tissue sarcomas. Eur J Cancer 2008, 44:1841-1845.
-
(2008)
Eur J Cancer
, vol.44
, pp. 1841-1845
-
-
Christie-Large, M.1
James, S.L.2
Tiessen, L.3
Davies, A.M.4
Grimer, R.J.5
-
32
-
-
79551511748
-
ACR Appropriateness Criteria screening for pulmonary metastases
-
Mohammed TL, Chowdhry A, Reddy GP, et al. ACR Appropriateness Criteria screening for pulmonary metastases. J Thorac Imaging 2011, 26:W1-W3.
-
(2011)
J Thorac Imaging
, vol.26
-
-
Mohammed, T.L.1
Chowdhry, A.2
Reddy, G.P.3
-
33
-
-
45549089411
-
Imaging guidelines for children with Ewing sarcoma and osteosarcoma: a report from the Children's Oncology Group Bone Tumor Committee
-
Meyer JS, Nadel HR, Marina N, et al. Imaging guidelines for children with Ewing sarcoma and osteosarcoma: a report from the Children's Oncology Group Bone Tumor Committee. Pediatr Blood Cancer 2008, 51:163-170.
-
(2008)
Pediatr Blood Cancer
, vol.51
, pp. 163-170
-
-
Meyer, J.S.1
Nadel, H.R.2
Marina, N.3
-
34
-
-
0022632860
-
MRI and CT evaluation of primary bone and soft-tissue tumors
-
Aisen AM, Martel W, Braunstein EM, et al. MRI and CT evaluation of primary bone and soft-tissue tumors. Am J Roentgenol 1986, 146:749-756.
-
(1986)
Am J Roentgenol
, vol.146
, pp. 749-756
-
-
Aisen, A.M.1
Martel, W.2
Braunstein, E.M.3
-
35
-
-
0023837535
-
Soft-tissue sarcomas of the extremities: comparison of MR and CT in determining the extent of disease
-
Demas BE, Heelan RT, Lane J, et al. Soft-tissue sarcomas of the extremities: comparison of MR and CT in determining the extent of disease. Am J Roentgenol 1988, 150:615-620.
-
(1988)
Am J Roentgenol
, vol.150
, pp. 615-620
-
-
Demas, B.E.1
Heelan, R.T.2
Lane, J.3
-
36
-
-
0031304588
-
Scintigraphically negative skip metastasis in osteosarcoma
-
Bhagia SM, Grimer RJ, Davies AM, Mangham DC Scintigraphically negative skip metastasis in osteosarcoma. Eur Radiol 1997, 7:1446-1448.
-
(1997)
Eur Radiol
, vol.7
, pp. 1446-1448
-
-
Bhagia, S.M.1
Grimer, R.J.2
Davies, A.M.3
Mangham, D.C.4
-
37
-
-
0033865698
-
FDG-PET for detection of osseous metastases from malignant primary bone tumours: comparison with bone scintigraphy
-
Franzius C, Sciuk J, Daldrup-Link HE, Jurgens H, Schober O FDG-PET for detection of osseous metastases from malignant primary bone tumours: comparison with bone scintigraphy. Eur J Nucl Med 2000, 27:1305-1311.
-
(2000)
Eur J Nucl Med
, vol.27
, pp. 1305-1311
-
-
Franzius, C.1
Sciuk, J.2
Daldrup-Link, H.E.3
Jurgens, H.4
Schober, O.5
-
38
-
-
0035019053
-
FDG-PET for detection of pulmonary metastases from malignant primary bone tumors: comparison with spiral CT
-
Franzius C, Daldrup-Link HE, Sciuk J, et al. FDG-PET for detection of pulmonary metastases from malignant primary bone tumors: comparison with spiral CT. Ann Oncol 2001, 12:479-486.
-
(2001)
Ann Oncol
, vol.12
, pp. 479-486
-
-
Franzius, C.1
Daldrup-Link, H.E.2
Sciuk, J.3
-
39
-
-
67650281750
-
Utilization of positron emission tomography in the management of patients with sarcoma
-
Benz MR, Tchekmedyian N, Eilber FC, Federman N, Czernin J, Tap WD Utilization of positron emission tomography in the management of patients with sarcoma. Curr Opin Oncol 2009, 21:345-351.
-
(2009)
Curr Opin Oncol
, vol.21
, pp. 345-351
-
-
Benz, M.R.1
Tchekmedyian, N.2
Eilber, F.C.3
Federman, N.4
Czernin, J.5
Tap, W.D.6
-
40
-
-
1242307295
-
The value of FDG-PET in the detection, grading and response to therapy of soft tissue and bone sarcomas; a systematic review and meta-analysis
-
Bastiaannet E, Groen H, Jager PL, et al. The value of FDG-PET in the detection, grading and response to therapy of soft tissue and bone sarcomas; a systematic review and meta-analysis. Cancer Treat Rev 2004, 30:83-101.
-
(2004)
Cancer Treat Rev
, vol.30
, pp. 83-101
-
-
Bastiaannet, E.1
Groen, H.2
Jager, P.L.3
-
41
-
-
0034054766
-
Clinical value of 18-Ffluorodeoxyglucose positron emission tomography imaging in soft tissue sarcomas
-
Schwarzbach MH, Dimitrakopoulou-Strauss A, Willeke F, et al. Clinical value of 18-Ffluorodeoxyglucose positron emission tomography imaging in soft tissue sarcomas. Ann Surg 2000, 231:380-386.
-
(2000)
Ann Surg
, vol.231
, pp. 380-386
-
-
Schwarzbach, M.H.1
Dimitrakopoulou-Strauss, A.2
Willeke, F.3
-
42
-
-
54349098061
-
Preoperative core biopsy of soft tissue tumours facilitates their surgical management: a 10-year update
-
Woon DT, Serpell JW Preoperative core biopsy of soft tissue tumours facilitates their surgical management: a 10-year update. ANZ J Surg 2008, 78:977-981.
-
(2008)
ANZ J Surg
, vol.78
, pp. 977-981
-
-
Woon, D.T.1
Serpell, J.W.2
-
43
-
-
77957352239
-
The role of core needle biopsy in the diagnosis of suspected soft tissue tumours
-
Strauss DC, Qureshi YA, Hayes AJ, Thway K, Fisher C, Thomas JM The role of core needle biopsy in the diagnosis of suspected soft tissue tumours. J Surg Oncol 2010, 102:523-529.
-
(2010)
J Surg Oncol
, vol.102
, pp. 523-529
-
-
Strauss, D.C.1
Qureshi, Y.A.2
Hayes, A.J.3
Thway, K.4
Fisher, C.5
Thomas, J.M.6
-
44
-
-
18244381541
-
Accuracy of computed tomography guided core needle biopsy of musculoskeletal tumours
-
Altuntas AO, Slavin J, Smith PJ, et al. Accuracy of computed tomography guided core needle biopsy of musculoskeletal tumours. ANZ J Surg 2005, 75:187-191.
-
(2005)
ANZ J Surg
, vol.75
, pp. 187-191
-
-
Altuntas, A.O.1
Slavin, J.2
Smith, P.J.3
-
45
-
-
70449519138
-
Biopsy of soft tissue masses: evidence-based medicine for the musculoskeletal tumor society
-
Rougraff BT, Aboulafia A, Biermann JS, Healey J Biopsy of soft tissue masses: evidence-based medicine for the musculoskeletal tumor society. Clin Orthop Relat Res 2009, 467:2783-2791.
-
(2009)
Clin Orthop Relat Res
, vol.467
, pp. 2783-2791
-
-
Rougraff, B.T.1
Aboulafia, A.2
Biermann, J.S.3
Healey, J.4
-
46
-
-
0342368637
-
Fine needle aspiration biopsy of primary bone tumors
-
Ward WG, Kilpatrick S Fine needle aspiration biopsy of primary bone tumors. Clin Orthop Relat Res 2000, 373:80-87.
-
(2000)
Clin Orthop Relat Res
, vol.373
, pp. 80-87
-
-
Ward, W.G.1
Kilpatrick, S.2
-
47
-
-
84880448846
-
-
IARC Press, Lyon
-
Fletcher C, Bridge JA, Hogendoorn P, Mertens F World Health Organization classification of tumours of soft tissue and bone 2013, IARC Press, Lyon. 4th edn.
-
(2013)
World Health Organization classification of tumours of soft tissue and bone
-
-
Fletcher, C.1
Bridge, J.A.2
Hogendoorn, P.3
Mertens, F.4
-
48
-
-
1942530423
-
Conventional osteosarcoma
-
IARC Press, Lyon, C.D.M. Fletcher, K.K. Unni, F. Mertens (Eds.)
-
Raymond A, Ayala A, Knuutila S Conventional osteosarcoma. World Health Organization classification of tumours pathology and genetics of tumours of soft tissue and bone 2002, 264-270. IARC Press, Lyon. C.D.M. Fletcher, K.K. Unni, F. Mertens (Eds.).
-
(2002)
World Health Organization classification of tumours pathology and genetics of tumours of soft tissue and bone
, pp. 264-270
-
-
Raymond, A.1
Ayala, A.2
Knuutila, S.3
-
49
-
-
0025915426
-
Immunohistochemical analysis of Ewing's sarcoma cell surface antigen p30/32MIC2
-
Fellinger EJ, Garin-Chesa P, Triche TJ, Huvos AG, Rettig WJ Immunohistochemical analysis of Ewing's sarcoma cell surface antigen p30/32MIC2. Am J Pathol 1991, 139:317-325.
-
(1991)
Am J Pathol
, vol.139
, pp. 317-325
-
-
Fellinger, E.J.1
Garin-Chesa, P.2
Triche, T.J.3
Huvos, A.G.4
Rettig, W.J.5
-
50
-
-
73349131509
-
Molecular diagnosis of Ewing sarcoma family of tumors: a comparative analysis of 560 cases with FISH and RT-PCR
-
Machado I, Noguera R, Pellin A, et al. Molecular diagnosis of Ewing sarcoma family of tumors: a comparative analysis of 560 cases with FISH and RT-PCR. Diagn Mol Pathol 2009, 18:189-199.
-
(2009)
Diagn Mol Pathol
, vol.18
, pp. 189-199
-
-
Machado, I.1
Noguera, R.2
Pellin, A.3
-
52
-
-
0027932782
-
The Ewing family of tumors-a subgroup of small-round-cell tumors defined by specific chimeric transcripts
-
Delattre O, Zucman J, Melot T, et al. The Ewing family of tumors-a subgroup of small-round-cell tumors defined by specific chimeric transcripts. N Engl J Med 1994, 331:294-299.
-
(1994)
N Engl J Med
, vol.331
, pp. 294-299
-
-
Delattre, O.1
Zucman, J.2
Melot, T.3
-
53
-
-
0032053388
-
Structural analysis of PAX3 genomic rearrangements in alveolar rhabdomyosarcoma
-
Barr FG, Nauta LE, Hollows JC Structural analysis of PAX3 genomic rearrangements in alveolar rhabdomyosarcoma. Cancer Genet Cytogenet 1998, 102:32-39.
-
(1998)
Cancer Genet Cytogenet
, vol.102
, pp. 32-39
-
-
Barr, F.G.1
Nauta, L.E.2
Hollows, J.C.3
-
54
-
-
70349451845
-
Clinical and biological significance of CDK4 amplification in well-differentiated and dedifferentiated liposarcomas
-
Italiano A, Bianchini L, Gjernes E, et al. Clinical and biological significance of CDK4 amplification in well-differentiated and dedifferentiated liposarcomas. Clin Cancer Res 2009, 15:5696-5703.
-
(2009)
Clin Cancer Res
, vol.15
, pp. 5696-5703
-
-
Italiano, A.1
Bianchini, L.2
Gjernes, E.3
-
55
-
-
79952216562
-
Liposarcoma: molecular genetics and therapeutics
-
Conyers R, Young S, Thomas DM Liposarcoma: molecular genetics and therapeutics. Sarcoma 2011, 2011:483154.
-
(2011)
Sarcoma
, vol.2011
, pp. 483154
-
-
Conyers, R.1
Young, S.2
Thomas, D.M.3
-
56
-
-
0031962230
-
Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity
-
Yang JC, Chang AE, Baker AR, et al. Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity. J Clin Oncol 1998, 16:197-203.
-
(1998)
J Clin Oncol
, vol.16
, pp. 197-203
-
-
Yang, J.C.1
Chang, A.E.2
Baker, A.R.3
-
57
-
-
0037193834
-
Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial
-
O'Sullivan B, Davis AM, Turcotte R, et al. Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial. Lancet 2002, 359:2235-2241.
-
(2002)
Lancet
, vol.359
, pp. 2235-2241
-
-
O'Sullivan, B.1
Davis, A.M.2
Turcotte, R.3
-
58
-
-
12744280714
-
Advanced-technology radiation therapy in the management of bone and soft tissue sarcomas
-
DeLaney TF, Trofimov AV, Engelsman M, Suit HD Advanced-technology radiation therapy in the management of bone and soft tissue sarcomas. Cancer Control 2005, 12:27-35.
-
(2005)
Cancer Control
, vol.12
, pp. 27-35
-
-
DeLaney, T.F.1
Trofimov, A.V.2
Engelsman, M.3
Suit, H.D.4
-
59
-
-
0033557981
-
Pelvic Ewing sarcoma: a retrospective analysis of 241 cases
-
Hoffmann C, Ahrens S, Dunst J, et al. Pelvic Ewing sarcoma: a retrospective analysis of 241 cases. Cancer 1999, 85:869-877.
-
(1999)
Cancer
, vol.85
, pp. 869-877
-
-
Hoffmann, C.1
Ahrens, S.2
Dunst, J.3
-
60
-
-
30544442756
-
Radiation therapy for Ewing's sarcoma: results from Memorial Sloan-Kettering in the modern era
-
La TH, Meyers PA, Wexler LH, et al. Radiation therapy for Ewing's sarcoma: results from Memorial Sloan-Kettering in the modern era. Int J Radiat Oncol Biol Phys 2006, 64:544-550.
-
(2006)
Int J Radiat Oncol Biol Phys
, vol.64
, pp. 544-550
-
-
La, T.H.1
Meyers, P.A.2
Wexler, L.H.3
-
61
-
-
0037963263
-
Preoperative vs. postoperative radiation therapy for soft tissue sarcoma: a retrospective comparative evaluation of disease outcome
-
Zagars GK, Ballo MT, Pisters PW, Pollock RE, Patel SR, Benjamin RS Preoperative vs. postoperative radiation therapy for soft tissue sarcoma: a retrospective comparative evaluation of disease outcome. Int J Radiat Oncol Biol Phys 2003, 56:482-488.
-
(2003)
Int J Radiat Oncol Biol Phys
, vol.56
, pp. 482-488
-
-
Zagars, G.K.1
Ballo, M.T.2
Pisters, P.W.3
Pollock, R.E.4
Patel, S.R.5
Benjamin, R.S.6
-
62
-
-
0037112244
-
Function and health status outcomes in a randomized trial comparing preoperative and postoperative radiotherapy in extremity soft tissue sarcoma
-
Davis AM, O'Sullivan B, Bell RS, et al. Function and health status outcomes in a randomized trial comparing preoperative and postoperative radiotherapy in extremity soft tissue sarcoma. J Clin Oncol 2002, 20:4472-4477.
-
(2002)
J Clin Oncol
, vol.20
, pp. 4472-4477
-
-
Davis, A.M.1
O'Sullivan, B.2
Bell, R.S.3
-
63
-
-
20944438542
-
Late radiation morbidity following randomization to preoperative versus postoperative radiotherapy in extremity soft tissue sarcoma
-
Davis AM, O'Sullivan B, Turcotte R, et al. Late radiation morbidity following randomization to preoperative versus postoperative radiotherapy in extremity soft tissue sarcoma. Radiother Oncol 2005, 75:48-53.
-
(2005)
Radiother Oncol
, vol.75
, pp. 48-53
-
-
Davis, A.M.1
O'Sullivan, B.2
Turcotte, R.3
-
64
-
-
2942588581
-
Intensity-modulated radiotherapy for soft tissue sarcoma of the thigh
-
Hong L, Alektiar KM, Hunt M, Venkatraman E, Leibel SA Intensity-modulated radiotherapy for soft tissue sarcoma of the thigh. Int J Radiat Oncol Biol Phys 2004, 59:752-759.
-
(2004)
Int J Radiat Oncol Biol Phys
, vol.59
, pp. 752-759
-
-
Hong, L.1
Alektiar, K.M.2
Hunt, M.3
Venkatraman, E.4
Leibel, S.A.5
-
65
-
-
0029918660
-
Long-term results of a prospective randomized trial of adjuvant brachytherapy in soft tissue sarcoma
-
Pisters PW, Harrison LB, Leung DH, Woodruff JM, Casper ES, Brennan MF Long-term results of a prospective randomized trial of adjuvant brachytherapy in soft tissue sarcoma. J Clin Oncol 1996, 14:859-868.
-
(1996)
J Clin Oncol
, vol.14
, pp. 859-868
-
-
Pisters, P.W.1
Harrison, L.B.2
Leung, D.H.3
Woodruff, J.M.4
Casper, E.S.5
Brennan, M.F.6
-
66
-
-
49049089340
-
A systematic meta-analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft-tissue sarcoma
-
Pervaiz N, Colterjohn N, Farrokhyar F, Tozer R, Figueredo A, Ghert M A systematic meta-analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft-tissue sarcoma. Cancer 2008, 113:573-581.
-
(2008)
Cancer
, vol.113
, pp. 573-581
-
-
Pervaiz, N.1
Colterjohn, N.2
Farrokhyar, F.3
Tozer, R.4
Figueredo, A.5
Ghert, M.6
-
67
-
-
84866901248
-
Adjuvant chemotherapy with doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC 62931): a multicentre randomised controlled trial
-
Woll PJ, Reichardt P, Le Cesne A, et al. Adjuvant chemotherapy with doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC 62931): a multicentre randomised controlled trial. Lancet Oncol 2012, 13:1045-1054.
-
(2012)
Lancet Oncol
, vol.13
, pp. 1045-1054
-
-
Woll, P.J.1
Reichardt, P.2
Le Cesne, A.3
-
68
-
-
0028334634
-
Adjuvant CYVADIC chemotherapy for adult soft tissue sarcoma-reduced local recurrence but no improvement in survival: a study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group
-
Bramwell V, Rouesse J, Steward W, et al. Adjuvant CYVADIC chemotherapy for adult soft tissue sarcoma-reduced local recurrence but no improvement in survival: a study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group. J Clin Oncol 1994, 12:1137-1149.
-
(1994)
J Clin Oncol
, vol.12
, pp. 1137-1149
-
-
Bramwell, V.1
Rouesse, J.2
Steward, W.3
-
69
-
-
61649089629
-
The end of adjuvant chemotherapy (adCT) era with doxorubicin-based regimen in resected high-grade soft tissue sarcoma (STS): pooled analysis of the two STBSG-EORTC phase III clinical trials
-
Le Cesne A, Van Glabbeke M, Woll PJ, et al. The end of adjuvant chemotherapy (adCT) era with doxorubicin-based regimen in resected high-grade soft tissue sarcoma (STS): pooled analysis of the two STBSG-EORTC phase III clinical trials. J Clin Oncol 2008, 26(suppl 15):10525.
-
(2008)
J Clin Oncol
, vol.26
, Issue.SUPPL. 15
, pp. 10525
-
-
Le Cesne, A.1
Van Glabbeke, M.2
Woll, P.J.3
-
70
-
-
9444228341
-
Neo-adjuvant chemotherapy for primary high-grade extremity soft tissue sarcoma
-
Grobmyer SR, Maki RG, Demetri GD, et al. Neo-adjuvant chemotherapy for primary high-grade extremity soft tissue sarcoma. Ann Oncol 2004, 15:1667-1672.
-
(2004)
Ann Oncol
, vol.15
, pp. 1667-1672
-
-
Grobmyer, S.R.1
Maki, R.G.2
Demetri, G.D.3
-
71
-
-
0035003544
-
A randomised phase II study on neo-adjuvant chemotherapy for 'high-risk' adult soft-tissue sarcoma
-
Gortzak E, Azzarelli A, Buesa J, et al. A randomised phase II study on neo-adjuvant chemotherapy for 'high-risk' adult soft-tissue sarcoma. Eur J Cancer 2001, 37:1096-1103.
-
(2001)
Eur J Cancer
, vol.37
, pp. 1096-1103
-
-
Gortzak, E.1
Azzarelli, A.2
Buesa, J.3
-
72
-
-
61649093785
-
Neo/adjuvant chemotherapy does not improve outcome in resected primary synovial sarcoma: a study of the French Sarcoma Group
-
Italiano A, Penel N, Robin YM, et al. Neo/adjuvant chemotherapy does not improve outcome in resected primary synovial sarcoma: a study of the French Sarcoma Group. Ann Oncol 2009, 20:425-430.
-
(2009)
Ann Oncol
, vol.20
, pp. 425-430
-
-
Italiano, A.1
Penel, N.2
Robin, Y.M.3
-
73
-
-
0023176119
-
Randomized comparison of three adriamycin regimens for metastatic soft tissue sarcomas
-
Borden EC, Amato DA, Rosenbaum C, et al. Randomized comparison of three adriamycin regimens for metastatic soft tissue sarcomas. J Clin Oncol 1987, 5:840-850.
-
(1987)
J Clin Oncol
, vol.5
, pp. 840-850
-
-
Borden, E.C.1
Amato, D.A.2
Rosenbaum, C.3
-
74
-
-
84861555286
-
-
WHO, (accessed Aug 14, 2013).
-
WHO model list of essential medicines WHO, (accessed Aug 14, 2013). http://www.who.int/medicines/publications/essentialmedicines/en/index.html.
-
WHO model list of essential medicines
-
-
-
75
-
-
0030912403
-
High-dose ifosfamide in bone and soft tissue sarcomas: results of phase II and pilot studies-dose-response and schedule dependence
-
Patel SR, Vadhan-Raj S, Papadopolous N, et al. High-dose ifosfamide in bone and soft tissue sarcomas: results of phase II and pilot studies-dose-response and schedule dependence. J Clin Oncol 1997, 15:2378-2384.
-
(1997)
J Clin Oncol
, vol.15
, pp. 2378-2384
-
-
Patel, S.R.1
Vadhan-Raj, S.2
Papadopolous, N.3
-
76
-
-
0024513428
-
Response to ifosfamide and mesna: 124 previously treated patients with metastatic or unresectable sarcoma
-
Antman KH, Ryan L, Elias A, Sherman D, Grier HE Response to ifosfamide and mesna: 124 previously treated patients with metastatic or unresectable sarcoma. J Clin Oncol 1989, 7:126-131.
-
(1989)
J Clin Oncol
, vol.7
, pp. 126-131
-
-
Antman, K.H.1
Ryan, L.2
Elias, A.3
Sherman, D.4
Grier, H.E.5
-
77
-
-
0036892122
-
Results of randomised studies of the EORTC Soft Tissue and Bone Sarcoma Group (STBSG) with two different ifosfamide regimens in first- and second-line chemotherapy in advanced soft tissue sarcoma patients
-
van Oosterom AT, Mouridsen HT, Nielsen OS, et al. Results of randomised studies of the EORTC Soft Tissue and Bone Sarcoma Group (STBSG) with two different ifosfamide regimens in first- and second-line chemotherapy in advanced soft tissue sarcoma patients. Eur J Cancer 2002, 38:2397-2406.
-
(2002)
Eur J Cancer
, vol.38
, pp. 2397-2406
-
-
van Oosterom, A.T.1
Mouridsen, H.T.2
Nielsen, O.S.3
-
78
-
-
0030726408
-
Phase II study of continuous-infusion high-dose ifosfamide in advanced and/or metastatic pretreated soft tissue sarcomas
-
Palumbo R, Palmeri S, Antimi M, et al. Phase II study of continuous-infusion high-dose ifosfamide in advanced and/or metastatic pretreated soft tissue sarcomas. Ann Oncol 1997, 8:1159-1162.
-
(1997)
Ann Oncol
, vol.8
, pp. 1159-1162
-
-
Palumbo, R.1
Palmeri, S.2
Antimi, M.3
-
79
-
-
84921702657
-
Doxorubicin-based chemotherapy for the palliative treatment of adult patients with locally advanced or metastatic soft tissue sarcoma
-
Sarcoma Disease Site Group, CD003293.
-
Bramwell VH, Anderson D, Charette ML Doxorubicin-based chemotherapy for the palliative treatment of adult patients with locally advanced or metastatic soft tissue sarcoma. Cochrane Database Syst Rev 2003, 3. Sarcoma Disease Site Group, CD003293.
-
(2003)
Cochrane Database Syst Rev
, vol.3
-
-
Bramwell, V.H.1
Anderson, D.2
Charette, M.L.3
-
80
-
-
0037096747
-
Gemcitabine and docetaxel in patients with unresectable leiomyosarcoma: results of a phase II trial
-
Hensley ML, Maki R, Venkatraman E, et al. Gemcitabine and docetaxel in patients with unresectable leiomyosarcoma: results of a phase II trial. J Clin Oncol 2002, 20:2824-2831.
-
(2002)
J Clin Oncol
, vol.20
, pp. 2824-2831
-
-
Hensley, M.L.1
Maki, R.2
Venkatraman, E.3
-
81
-
-
33745444832
-
Docetaxel and gemcitabine combination in 133 advanced soft-tissue sarcomas: a retrospective analysis
-
Bay JO, Ray-Coquard I, Fayette J, et al. Docetaxel and gemcitabine combination in 133 advanced soft-tissue sarcomas: a retrospective analysis. Int J Cancer 2006, 119:706-711.
-
(2006)
Int J Cancer
, vol.119
, pp. 706-711
-
-
Bay, J.O.1
Ray-Coquard, I.2
Fayette, J.3
-
82
-
-
70249101414
-
Efficacy and safety of trabectedin in patients with advanced or metastatic liposarcoma or leiomyosarcoma after failure of prior anthracyclines and ifosfamide: results of a randomized phase II study of two different schedules
-
Demetri GD, Chawla SP, von Mehren M, et al. Efficacy and safety of trabectedin in patients with advanced or metastatic liposarcoma or leiomyosarcoma after failure of prior anthracyclines and ifosfamide: results of a randomized phase II study of two different schedules. J Clin Oncol 2009, 27:4188-4196.
-
(2009)
J Clin Oncol
, vol.27
, pp. 4188-4196
-
-
Demetri, G.D.1
Chawla, S.P.2
von Mehren, M.3
-
83
-
-
55949086834
-
Phase II trial of weekly paclitaxel for unresectable angiosarcoma: the ANGIOTAX Study
-
Penel N, Bui BN, Bay JO, et al. Phase II trial of weekly paclitaxel for unresectable angiosarcoma: the ANGIOTAX Study. J Clin Oncol 2008, 26:5269-5274.
-
(2008)
J Clin Oncol
, vol.26
, pp. 5269-5274
-
-
Penel, N.1
Bui, B.N.2
Bay, J.O.3
-
84
-
-
84861098484
-
Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial
-
van der Graaf WT, Blay JY, Chawla SP, et al. Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet 2012, 379:1879-1886.
-
(2012)
Lancet
, vol.379
, pp. 1879-1886
-
-
van der Graaf, W.T.1
Blay, J.Y.2
Chawla, S.P.3
-
85
-
-
14144256775
-
Molecular and clinical analysis of locally advanced dermatofibrosarcoma protuberans treated with imatinib: Imatinib Target Exploration Consortium Study B2225
-
McArthur GA, Demetri GD, Van Oosterom A, et al. Molecular and clinical analysis of locally advanced dermatofibrosarcoma protuberans treated with imatinib: Imatinib Target Exploration Consortium Study B2225. J Clin Oncol 2005, 23:866-873.
-
(2005)
J Clin Oncol
, vol.23
, pp. 866-873
-
-
McArthur, G.A.1
Demetri, G.D.2
Van Oosterom, A.3
-
86
-
-
0037103424
-
Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors
-
Demetri GD, von Mehren M, Blanke CD, et al. Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl J Med 2002, 347:472-480.
-
(2002)
N Engl J Med
, vol.347
, pp. 472-480
-
-
Demetri, G.D.1
von Mehren, M.2
Blanke, C.D.3
-
87
-
-
0043246702
-
Predictive pathology: a pathologist's perspective
-
Waring P Predictive pathology: a pathologist's perspective. Cancer Forum 2003, 27:100-101.
-
(2003)
Cancer Forum
, vol.27
, pp. 100-101
-
-
Waring, P.1
-
88
-
-
84876171885
-
India's patent case victory rattles Big Pharma
-
Chatterjee P India's patent case victory rattles Big Pharma. Lancet 2013, 381:1263.
-
(2013)
Lancet
, vol.381
, pp. 1263
-
-
Chatterjee, P.1
-
89
-
-
84861214958
-
Rhabdomyosarcoma: review of the Children's Oncology Group (COG) soft-tissue Sarcoma committee experience and rationale for current COG studies
-
Malempati S, Hawkins DS Rhabdomyosarcoma: review of the Children's Oncology Group (COG) soft-tissue Sarcoma committee experience and rationale for current COG studies. Pediatr Blood Cancer 2012, 59:5-10.
-
(2012)
Pediatr Blood Cancer
, vol.59
, pp. 5-10
-
-
Malempati, S.1
Hawkins, D.S.2
-
90
-
-
0037456435
-
Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone
-
Grier HE, Krailo MD, Tarbell NJ, et al. Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone. N Engl J Med 2003, 348:694-701.
-
(2003)
N Engl J Med
, vol.348
, pp. 694-701
-
-
Grier, H.E.1
Krailo, M.D.2
Tarbell, N.J.3
-
91
-
-
70249094258
-
Methotrexate for high-grade osteosarcoma in children and young adults
-
CD006325.
-
Van Dalen EC, de Camargo B Methotrexate for high-grade osteosarcoma in children and young adults. Cochrane Database Syst Rev 2009, 1. CD006325.
-
(2009)
Cochrane Database Syst Rev
, vol.1
-
-
Van Dalen, E.C.1
de Camargo, B.2
-
92
-
-
33644837672
-
Neoadjuvant chemotherapy with high-dose ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma Groups
-
Ferrari S, Smeland S, Mercuri M, et al. Neoadjuvant chemotherapy with high-dose ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma Groups. J Clin Oncol 2005, 23:8845-8852.
-
(2005)
J Clin Oncol
, vol.23
, pp. 8845-8852
-
-
Ferrari, S.1
Smeland, S.2
Mercuri, M.3
-
93
-
-
0038688477
-
Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols
-
Kager L, Zoubek A, Potschger U, et al. Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols. J Clin Oncol 2003, 21:2011-2018.
-
(2003)
J Clin Oncol
, vol.21
, pp. 2011-2018
-
-
Kager, L.1
Zoubek, A.2
Potschger, U.3
-
94
-
-
0025008189
-
Multimodal therapy for the management of primary, nonmetastatic Ewing's sarcoma of bone: a long-term follow-up of the First Intergroup study
-
Nesbit ME, Gehan EA, Burgert EO, et al. Multimodal therapy for the management of primary, nonmetastatic Ewing's sarcoma of bone: a long-term follow-up of the First Intergroup study. J Clin Oncol 1990, 8:1664-1674.
-
(1990)
J Clin Oncol
, vol.8
, pp. 1664-1674
-
-
Nesbit, M.E.1
Gehan, E.A.2
Burgert, E.O.3
-
95
-
-
0034005161
-
Neoadjuvant chemotherapy for Ewing's sarcoma of bone in patients older than thirty-nine years
-
Bacci G, Ferrari S, Comandone A, et al. Neoadjuvant chemotherapy for Ewing's sarcoma of bone in patients older than thirty-nine years. Acta Oncol 2000, 39:111-116.
-
(2000)
Acta Oncol
, vol.39
, pp. 111-116
-
-
Bacci, G.1
Ferrari, S.2
Comandone, A.3
-
96
-
-
10744231796
-
Long-term outcome for patients with non-metastatic Ewing's sarcoma treated with adjuvant and neoadjuvant chemotherapies. 402 patients treated at Rizzoli between 1972 and 1992
-
Bacci G, Forni C, Longhi A, et al. Long-term outcome for patients with non-metastatic Ewing's sarcoma treated with adjuvant and neoadjuvant chemotherapies. 402 patients treated at Rizzoli between 1972 and 1992. Eur J Cancer 2004, 40:73-83.
-
(2004)
Eur J Cancer
, vol.40
, pp. 73-83
-
-
Bacci, G.1
Forni, C.2
Longhi, A.3
-
97
-
-
33646859458
-
Ewing's sarcoma family of tumors: current management
-
Bernstein M, Kovar H, Paulussen M, et al. Ewing's sarcoma family of tumors: current management. Oncologist 2006, 11:503-519.
-
(2006)
Oncologist
, vol.11
, pp. 503-519
-
-
Bernstein, M.1
Kovar, H.2
Paulussen, M.3
-
98
-
-
52449094980
-
Results of the EICESS-92 Study: two randomized trials of Ewing's sarcoma treatment-cyclophosphamide compared with ifosfamide in standard-risk patients and assessment of benefit of etoposide added to standard treatment in high-risk patients
-
Paulussen M, Craft AW, Lewis I, et al. Results of the EICESS-92 Study: two randomized trials of Ewing's sarcoma treatment-cyclophosphamide compared with ifosfamide in standard-risk patients and assessment of benefit of etoposide added to standard treatment in high-risk patients. J Clin Oncol 2008, 26:4385-4393.
-
(2008)
J Clin Oncol
, vol.26
, pp. 4385-4393
-
-
Paulussen, M.1
Craft, A.W.2
Lewis, I.3
-
99
-
-
33748476296
-
Impact of high-dose busulfan plus melphalan as consolidation in metastatic Ewing tumors: a study by the Societe Francaise des Cancers de l'Enfant
-
Oberlin O, Rey A, Desfachelles AS, et al. Impact of high-dose busulfan plus melphalan as consolidation in metastatic Ewing tumors: a study by the Societe Francaise des Cancers de l'Enfant. J Clin Oncol 2006, 24:3997-4002.
-
(2006)
J Clin Oncol
, vol.24
, pp. 3997-4002
-
-
Oberlin, O.1
Rey, A.2
Desfachelles, A.S.3
-
100
-
-
0035368059
-
High-dose melphalan, etoposide, total-body irradiation, and autologous stem-cell reconstitution as consolidation therapy for high-risk Ewing's sarcoma does not improve prognosis
-
Meyers PA, Krailo MD, Ladanyi M, et al. High-dose melphalan, etoposide, total-body irradiation, and autologous stem-cell reconstitution as consolidation therapy for high-risk Ewing's sarcoma does not improve prognosis. J Clin Oncol 2001, 19:2812-2820.
-
(2001)
J Clin Oncol
, vol.19
, pp. 2812-2820
-
-
Meyers, P.A.1
Krailo, M.D.2
Ladanyi, M.3
-
101
-
-
0029073772
-
Impact of megatherapy in children with high-risk Ewing's tumours in complete remission: a report from the EBMT Solid Tumour Registry
-
Ladenstein R, Lasset C, Pinkerton R, et al. Impact of megatherapy in children with high-risk Ewing's tumours in complete remission: a report from the EBMT Solid Tumour Registry. Bone Marrow Transplant 1995, 15:697-705.
-
(1995)
Bone Marrow Transplant
, vol.15
, pp. 697-705
-
-
Ladenstein, R.1
Lasset, C.2
Pinkerton, R.3
-
102
-
-
79952020083
-
High-dose chemotherapy followed by autologous stem cell transplantation for metastatic rhabdomyosarcoma-a systematic review
-
Peinemann F, Kroger N, Bartel C, et al. High-dose chemotherapy followed by autologous stem cell transplantation for metastatic rhabdomyosarcoma-a systematic review. PLoS One 2011, 6:e17127.
-
(2011)
PLoS One
, vol.6
-
-
Peinemann, F.1
Kroger, N.2
Bartel, C.3
-
103
-
-
79952202135
-
High-dose chemotherapy for children and young adults with stage IV rhabdomyosarcoma
-
CD006669.
-
Admiraal R, van der Paardt M, Kobes J, Kremer LC, Bisogno G, Merks JH High-dose chemotherapy for children and young adults with stage IV rhabdomyosarcoma. Cochrane Database Syst Rev 2010, 12. CD006669.
-
(2010)
Cochrane Database Syst Rev
, vol.12
-
-
Admiraal, R.1
van der Paardt, M.2
Kobes, J.3
Kremer, L.C.4
Bisogno, G.5
Merks, J.H.6
-
104
-
-
77954031237
-
Sequelae of osteosarcoma medical therapy: a review of rare acute toxicities and late effects
-
Janeway KA, Grier HE Sequelae of osteosarcoma medical therapy: a review of rare acute toxicities and late effects. Lancet Oncol 2010, 11:670-678.
-
(2010)
Lancet Oncol
, vol.11
, pp. 670-678
-
-
Janeway, K.A.1
Grier, H.E.2
-
105
-
-
0027082303
-
A comparison of two short intensive adjuvant chemotherapy regimens in operable osteosarcoma of limbs in children and young adults: the first study of the European Osteosarcoma Intergroup
-
Bramwell VH, Burgers M, Sneath R, et al. A comparison of two short intensive adjuvant chemotherapy regimens in operable osteosarcoma of limbs in children and young adults: the first study of the European Osteosarcoma Intergroup. J Clin Oncol 1992, 10:1579-1591.
-
(1992)
J Clin Oncol
, vol.10
, pp. 1579-1591
-
-
Bramwell, V.H.1
Burgers, M.2
Sneath, R.3
-
106
-
-
80054914908
-
Chemotherapeutic adjuvant treatment for osteosarcoma: where do we stand?
-
Anninga JK, Gelderblom H, Fiocco M, et al. Chemotherapeutic adjuvant treatment for osteosarcoma: where do we stand?. Eur J Cancer 2011, 47:2431-2445.
-
(2011)
Eur J Cancer
, vol.47
, pp. 2431-2445
-
-
Anninga, J.K.1
Gelderblom, H.2
Fiocco, M.3
-
107
-
-
84869447819
-
Randomized controlled trial of interval-compressed chemotherapy for the treatment of localized Ewing sarcoma: a report from the Children's Oncology Group
-
Womer RB, West DC, Krailo MD, et al. Randomized controlled trial of interval-compressed chemotherapy for the treatment of localized Ewing sarcoma: a report from the Children's Oncology Group. J Clin Oncol 2012, 30:4148-4154.
-
(2012)
J Clin Oncol
, vol.30
, pp. 4148-4154
-
-
Womer, R.B.1
West, D.C.2
Krailo, M.D.3
-
108
-
-
34547186749
-
Analysis of prognostic factors in ewing sarcoma family of tumors: review of St. Jude Children's Research Hospital studies
-
Rodriguez-Galindo C, Liu T, Krasin MJ, et al. Analysis of prognostic factors in ewing sarcoma family of tumors: review of St. Jude Children's Research Hospital studies. Cancer 2007, 110:375-384.
-
(2007)
Cancer
, vol.110
, pp. 375-384
-
-
Rodriguez-Galindo, C.1
Liu, T.2
Krasin, M.J.3
-
109
-
-
84874014664
-
Incidence and survival rates among pediatric osteogenic sarcoma cases in Khon Kaen, Thailand, 1985-2010
-
Wiromrat P, Jetsrisuparb A, Komvilaisak P, Sirichativapee W, Kamsa-ard S, Wiangnon S Incidence and survival rates among pediatric osteogenic sarcoma cases in Khon Kaen, Thailand, 1985-2010. Asian Pac J Cancer Prev 2012, 13:4281-4284.
-
(2012)
Asian Pac J Cancer Prev
, vol.13
, pp. 4281-4284
-
-
Wiromrat, P.1
Jetsrisuparb, A.2
Komvilaisak, P.3
Sirichativapee, W.4
Kamsa-ard, S.5
Wiangnon, S.6
-
110
-
-
84874106283
-
Analysis of prognostic factors in 333 Chinese patients with high-grade osteosarcoma treated by multidisciplinary combined therapy
-
Min D, Lin F, Shen Z, et al. Analysis of prognostic factors in 333 Chinese patients with high-grade osteosarcoma treated by multidisciplinary combined therapy. Asia Pac J Clin Oncol 2013, 9:71-79.
-
(2013)
Asia Pac J Clin Oncol
, vol.9
, pp. 71-79
-
-
Min, D.1
Lin, F.2
Shen, Z.3
-
111
-
-
33947181705
-
-
WHO, (accessed Oct 2, 2013).
-
WHO's pain ladder WHO, (accessed Oct 2, 2013). http://www.who.int/cancer/palliative/painladder/en/.
-
WHO's pain ladder
-
-
-
112
-
-
84874954241
-
SIOP-PODC recommendations for graduated-intensity treatment of retinoblastoma in developing countries
-
Chantada G, Luna-Fineman S, Sitorus RS, et al. SIOP-PODC recommendations for graduated-intensity treatment of retinoblastoma in developing countries. Pediatr Blood Cancer 2013, 60:719-727.
-
(2013)
Pediatr Blood Cancer
, vol.60
, pp. 719-727
-
-
Chantada, G.1
Luna-Fineman, S.2
Sitorus, R.S.3
-
113
-
-
79960892299
-
Abandonment of treatment for childhood cancer: position statement of a SIOP PODC Working Group
-
Mostert S, Arora RS, Arreola M, et al. Abandonment of treatment for childhood cancer: position statement of a SIOP PODC Working Group. Lancet Oncol 2011, 12:719-720.
-
(2011)
Lancet Oncol
, vol.12
, pp. 719-720
-
-
Mostert, S.1
Arora, R.S.2
Arreola, M.3
-
114
-
-
84870219145
-
Chemotherapy compliance in patients with osteosarcoma
-
Bajpai J, Puri A, Shah K, et al. Chemotherapy compliance in patients with osteosarcoma. Pediatr Blood Cancer 2013, 60:41-44.
-
(2013)
Pediatr Blood Cancer
, vol.60
, pp. 41-44
-
-
Bajpai, J.1
Puri, A.2
Shah, K.3
-
115
-
-
84866147628
-
Suboptimal chemotherapy is an adverse prognostic factor in osteosarcoma
-
Yong B, Tan P, Yin J, et al. Suboptimal chemotherapy is an adverse prognostic factor in osteosarcoma. World J Surg Oncol 2012, 10:191.
-
(2012)
World J Surg Oncol
, vol.10
, pp. 191
-
-
Yong, B.1
Tan, P.2
Yin, J.3
|